跳至主要内容
临床试验/KCT0004384
KCT0004384
尚未招募
未知

Efficacy and Safety of laser surgery 'Liposci' procedure in initial validity reduction of abdominal circumference : A Single-blind Randomized Clinical Trial

WONTECH0 个研究点目标入组 20 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Factors influencing health status and contact with health servisces
发起方
WONTECH
入组人数
20
状态
尚未招募
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
6年前
研究类型
Interventional Study
性别
All

研究者

发起方
WONTECH

入排标准

入选标准

  • 1\. Adult male or female over 19 years of age.
  • 2\. BMI (Body mass index) \= 35 kg/m2
  • 3\. If the thickness of the lower abdomen fat measured using Caliper is greater than 2\.5 cm.
  • 4\. No other treatment is planned for body contouring or weight loss during this clinical trial.
  • 5\. If you agree to keep your weight (within ± 5%) by not changing your diet or lifestyle
  • 6\. Voluntarily decided to participate in this clinical trial and gave written consent

排除标准

  • 1\. pregnant, nursing, or women planning to conceive within the clinical trial period or who do not agree to the proper use of contraceptives during the clinical trial period.
  • 2\. In case of history or related treatment of blood clotting disorder (anti\-platelet, anticoagulant, thrombotic release, aspirin, anti\-inflammatory drugs)
  • 3\. If you have experience with esthetic treatment in the treatment area within 12 months prior to the screening, or with surgical treatment to remove abdominal fat (fat\-absorbent, laparotomy, mezzoterapi, etc.)
  • 4\. In case there are implanted electrical devices such as pacemaker and defibrillator.
  • 5\. Unregulated diabetes or cardiovascular disease
  • 6\. For LDL cholesterol \= 190 mg/dL
  • 7\. Patient is diagnosed with hepatitis and is in treatment 3 or within 12 months of the end of hepatitis treatment
  • 8\. Surgical operation on the surgical site within 18 months of screening
  • 9\. If there is a history of skin cancer or pre\-cancerous lesions in the treatment area
  • 10\. In case there is a skin condition, such as infection, injury, and scarring, in the area of treatment

结局指标

主要结局

未指定

相似试验